These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24378771)

  • 1. Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice.
    Khunti K; Vora J; Davies M
    Prim Care Diabetes; 2014 Apr; 8(1):57-63. PubMed ID: 24378771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes.
    Levin PA; Wei W; Zhou S; Xie L; Baser O
    J Manag Care Spec Pharm; 2014 May; 20(5):501-12. PubMed ID: 24761822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice.
    Khunti K; Damci T; Meneghini L; Pan CY; Yale JF;
    Diabetes Obes Metab; 2012 Jul; 14(7):654-61. PubMed ID: 22443213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.
    Khunti K; Millar-Jones D
    Prim Care Diabetes; 2017 Feb; 11(1):3-12. PubMed ID: 27727005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010).
    Kostev K; Rathmann W
    Prim Care Diabetes; 2013 Oct; 7(3):229-33. PubMed ID: 23608219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Once daily insulin detemir in patients with type 2 diabetes: results of German centers in a 6-month international observational study (SOLVE)].
    Liebl A; Wilhelm B; Kaiser M
    MMW Fortschr Med; 2012 Dec; 154 Suppl 4():102-9. PubMed ID: 23326928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria influencing the choice of starting insulin regimen in patients with type 2 diabetes in routine clinical practice: baseline data from the Algerian cohort of the A₁chieve study.
    Malek R; Arbouche Z; Bachaoui M; Zinai S; Dahaoui A; Senoussaoui S; Salah-Mansour A
    Diabetes Res Clin Pract; 2013 Aug; 101 Suppl 1():S45-9. PubMed ID: 23958572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualised treatment targets in patients with type-2 diabetes and hypertension.
    Schmieder RE; Tschöpe D; Koch C; Ouarrak T; Gitt AK;
    Cardiovasc Diabetol; 2018 Jan; 17(1):18. PubMed ID: 29357854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.
    Liebl A; Prager R; Binz K; Kaiser M; Bergenstal R; Gallwitz B;
    Diabetes Obes Metab; 2009 Jan; 11(1):45-52. PubMed ID: 18643839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
    Seufert J; Pegelow K; Bramlage P
    Vasc Health Risk Manag; 2013; 9():711-7. PubMed ID: 24259985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with insulin detemir: results from the Indonesian cohort of the international A₁chieve study.
    Soewondo P; Kshanti IA; Pramono RB; Langi YA; Dalem-Pemayun TG
    Diabetes Res Clin Pract; 2013 Apr; 100 Suppl 1():S47-53. PubMed ID: 23647719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial.
    Manski-Nankervis JA; Furler J; O'Neal D; Ginnivan L; Thuraisingam S; Blackberry I
    Prim Care Diabetes; 2017 Oct; 11(5):474-481. PubMed ID: 28705697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study.
    Maguire A; Mitchell BD; Ruzafa JC
    BMC Endocr Disord; 2014 Aug; 14():73. PubMed ID: 25163796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study.
    Meneghini LF; Dornhorst A; Sreenan S;
    Curr Med Res Opin; 2009 Apr; 25(4):1029-35. PubMed ID: 19281426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study.
    Meneghini LF; Rosenberg KH; Koenen C; Merilainen MJ; Lüddeke HJ
    Diabetes Obes Metab; 2007 May; 9(3):418-27. PubMed ID: 17391170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
    Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH
    Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.